Author: Grazia Maria Cozzupoli (Italy)
Co-authors: Grazia Maria Cozzupoli, Borrelli Enrico, Sacconi Riccardo, Vittorio Capuano, Eric Souied, Giuseppe Querques
Purpose
The purpose of our study was to develop a novel scoring system aiming at guiding the differential diagnosis between pachychoroid neovasculopathy (PNV) and neovascular age-related macular degeneration (AMD) in patients affected by macular neovascularization (MNV) aged 50 years and older.
Setting/Venue
Multicenter retrospective study performed at University Vita-Salute San Raffaele (Milan, Italy) and Creteil University Eye Clinic (Paris, France).
Methods
We included consecutive patients who were diagnosed with either treatment-naïve PNV or nAMD, and who were 50 years of age and older. At the time of diagnosis, all patients underwent comprehensive ophthalmologic evaluation including best-corrected visual acuity (BCVA) assessment, slit-lamp biomicroscopy and fundus examination by an experienced retina specialist, infrared reflectance (IR), fundus autofluorescence (FAF), spectral-domain optical coherence tomography (SD-OCT), fluorescein angiography (FA), indocyanine green angiography (IA) and optical coherence tomography angiography (OCTA). Univariate comparison between PNV and neovascular AMD group was performed to identify the main clinical predictors for PNV. The selected predictors were taken into a binomial logistic regression and eventually served as the basis for the development of a scoring system, dubbed InCASEOf scoring system. Receiver operating characteristic (ROC) curves were used to study the model performance.
Results
Fifty-three eyes from 53 patients with MNV secondary to pachychoroid and 39 eyes from 39 patients with neovascular AMD were considered in this study. Age, sex, choroidal thickness, early pachyvessels, and evidence of MNV at OCTA were factors associated with an increased likelihood of exhibiting PNV. InCASEOf scoring system with a high score of 7 points was built based on these results and the cutoff value of 4.5 showed good accuracy in separating PNVs from neovascular AMDs.
Conlusions
This is the first study to develop and propose a straightforward clinical scoring system, accessible to comprehensive ophthalmologists, with the purpose of enabling easy distinction and expert-like diagnosis of PNV and neovascular AMD in patients aged 50 years or older.
Financial Disclosure
We do not have financial disclosure.
Comments
-